Evidence map›Paper›PMID 32954234›Full record

ArticleEClinicalMedicine2020

Rate and impact of duodenoscope contamination: A systematic review and meta-analysis.

Sara Larsen, Rasmus Vinther Russell, Lotte Klinten Ockert, Stephen Spanos, Helena Strømstad Travis, Lars Holger Ehlers, Anders Mærkedahl

Abstract read
In one paragraph

Article in EClinicalMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara LarsenAmbu A/S, Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark.
Rasmus Vinther RussellAmbu A/S, Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark.
Lotte Klinten OckertAmbu A/S, Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark.
Stephen SpanosAnesthesia and Acute Pain Department of Anesthesia University of Utah Primary Children's Hospital, United States.
Helena Strømstad TravisSchool of Medicine and Health, Aalborg University, Aalborg, Denmark.
Lars Holger EhlersDepartment of Business and Management, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark.
Anders MærkedahlNordic HTA, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple infection outbreaks have been linked to contaminated duodenoscopes worldwide. However, the contamination rate of patient-ready duodenoscopes varies highly amongst published studies testing this subject. We aimed to estimate the contamination rate of reprocessed patient-ready duodenoscopes for endoscopic retrograde cholangio-pancreatography (ERCP) based on currently available data.

methodsWe searched the PubMed and Embase databases from January 1, 2010 until March 10, 2020, for citations investigating contamination rates of reprocessed patient-ready duodenoscopes. Studies not assessing other types of endoscopes than duodenoscopes were excluded from the analysis. Study eligibility and data extraction was evaluated by three reviewers independently. A random-effects model (REM) based on the proportion distribution was used to calculate the pooled total contamination rate of reprocessed patient-ready duodenoscopes. Subgroup analyses were carried out to assess contamination rates when using different reprocessing methods by comparing single high-level disinfection (HLD) with double HLD and ethylene oxide (EtO) gas sterilization. Additionally, we investigated the contamination rate between studies conducted following an outbreak compared to non-outbreak-initiated studies.

findingsWe identified 15 studies that fulfilled the inclusion, which included 925 contaminated duodenoscopes from 13,112 samples. The calculated total weighted contamination rate was 15.25% ± 0.018 (95% confidence interval [Cl]: 11.74% - 18.75%). The contamination rate after only using HLD was 16.14% ± 0.019 (95% Cl: 12.43% - 19.85%) and after using either dHLD or EtO the contamination rate decreased to 9.20% ± 0.025 (95% Cl: 4.30% - 14.10%). Studies conducted following an outbreak (n=4) showed a 5.72% ± 0.034 (95% Cl: 0.00% - 12.43%) contamination rate, and non-outbreak-initiated studies (n=11) revealed a contamination rate of 21.50% ± 0.031 (95% Cl: 15.35% - 27.64%).

interpretationThis is the first meta-analysis to estimate the contamination rate of patient-ready duodenoscopes used for ERCP. Based on the available literature, our analysis demonstrates that there is a 15.25% contamination rate of reprocessed patient-ready duodenoscopes. Additionally, the analysis indicates that dHLD and EtO reprocessing methods are superior to single HLD but still not efficient in regards to cleaning the duodenoscopes properly. Furthermore, studies conducted following an outbreak did not entail a higher contamination rate compared to non-outbreak-initiated studies.

fundingThe authors received no financial support for the research, authorship, and/or publication of this article.

Indexed as

AGA, American Gastroenterological AssociationAORN, The Joint Commission and The Association of Perioperative Registered NursesBacterial*CDC, Center for Disease Control and PreventionCFU, colony-forming unitsCl, confidence intervalCRE, carbapenem-resistant EnterobacteriaceaeCross infectiondHLD, double high-level disinfectionDrug ResistanceDuodenoscopesEquipment contaminationERCI, Environmental Risk Communications, Inc.ERCP, endoscopic retrograde cholangio-pancreatographyEtO, ethylene oxideFDA, Food & Drug AdministrationHLD, high-level disinfectionInfection ControlMDR, multi-drug-resistantMeSH, medical subject headingsMultiplePRISMA, Preferred Reporting Items for Systematic Reviews and Meta-AnalysesREM, random-effects model

Identifiers

PMID32954234
PMCPMC7486302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.